Oxford-AstraZeneca Covid-19 vaccine approved by U.K. regulator
UK May Approve AstraZeneca Covid-19 Vaccine This Week
The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is expected to be approved for use in the UK in the coming days.
The Financial Times reported Sunday that government officials have confirmed that the Medicines and Healthcare products Regulatory Agency will approve the vaccine soon, saying it might announce it tomorrow on Tuesday. … The Sunday Telegraph reported that approval could be obtained as early as today, saying that healthcare workers are preparing to receive the first vaccinations with the vaccine..
But the regulator remained silent, and the UK Health Department told Reuters the agency should be given time to properly assess the vaccine trial data..
British minister Michael Gove (Michael Gove) also said nothing in a media interview Monday morning, but said the vaccine authorization could expedite the lifting of strict restrictions in the country that effectively canceled the Christmas holidays for many millions..
The UK reported about 30,500 daily infections and 316 deaths on Sunday, but those numbers could be underreported due to reporting delays. Cases have skyrocketed in London and the south of England, putting pressure on hospitals. A new variant of the coronavirus found in the UK is reportedly more contagious and has led to travel restrictions for people wanting to leave the country..
The AstraZeneca vaccine is likely to be launched next week, if approved in the next few days, and will add to the pandemic arsenal on par with the Pfizer-BioNTech vaccine, which according to government statistics, has received 600,000 people in the UK to date..
The Oxford-AstraZeneca vaccine candidate will allow the country to significantly step up its vaccination program, given its development in the UK. It is also much cheaper than other counterparts and does not require ultra low temperature maintenance..
Earlier this month, Dr. Richard Horton (Richard Horton), editor-in-chief of the medical journal The Lancet, told CNBC the vaccine can be used more effectively worldwide than others.
«The Oxford / AstraZeneca vaccine right now is the vaccine that can immunize the planet more efficiently and faster than any other vaccine we have.», – said Horton, adding that it is important to think about immunizing the population with this vaccine globally, «because even if we immunize one country, the threat is that you will re-introduce the virus from another unprotected country».
The confusion around the test data in November prompted some criticism of the British design. Data shows the vaccine could help reduce the spread of Covid-19, as well as prevent illness and death. The study also found that it was 62% effective for trial participants who received two full doses and 90% for a subgroup who received half the dose followed by a full dose..
But the White House chief of operations "Warp Speed" In the meantime, there is no need to worry about it. ”Moncef Sloughie (Moncef Slaoui) and others in the US raised concerns about the age group tested, saying that 90% efficacy was demonstrated only for the lowest-risk group of 2,741 people under the age of 55.
Pascal Sorio (Pascal Soriot), CEO of AstraZeneca, said the pharmaceutical giant will conduct an additional global trial to evaluate the effectiveness of its vaccine. Sorio told The Times this weekend that he is convinced that subsequent data will show that his company’s vaccine has achieved a level of effectiveness equal to other products from other businesses, over 90%..
«We think that we have found a winning formula and how to achieve an effectiveness that, after two doses, is not inferior to everyone else.», – he said. «I can’t tell you more because we will publish this at some stage».
He added that AstraZeneca believes the vaccine will be effective against the new strain of coronavirus, but is conducting tests to confirm this..